[
 {
  "document": {
   "authors": "Farah Humayun",
   "contact_info": "farah.humayun@scai-extern.fraunhofer.de",
   "description": "Heme BEL model is a disease model based on Biological Expression Language(BEL) containing the core mechanisms of heme as modulator in Hemolytic diseases such as sickle-cell anemia, beta-thalassemia, malaria and autoimmune hemolytic anemia.",
   "licences": "MIT License",
   "name": "heme_30281034.bel",
   "version": "1.0.0"
  }
 },
 {
  "definitions": [
   {
    "namespace": {
     "keyword": "MGI",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "mgi",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "mgi",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "mgi",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "chebi",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "drugbank",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "ECCODE",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "HBP",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/export/hbp-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "hgnc",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "HGNCGENEFAMILY",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "go",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "interpro",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "MeSH",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "mgi",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "mirbase",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "ncbigene",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "pfam",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "rgd",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "FPLX",
     "type": "URL",
     "value": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "CTO",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "DO",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "HP",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "SCOMP",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "SFAM",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "DBSNP",
     "type": "PATTERN",
     "value": "rs[0-9]+",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "TAXONOMY",
     "type": "PATTERN",
     "value": "^\\d+$",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "UNIPROT",
     "type": "PATTERN",
     "value": "^([A-N,R-Z][0-9]([A-Z][A-Z,0-9][A-Z,0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z,0-9][A-Z,0-9][A-Z,0-9][0-9])(\\.\\d+)?$",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "PUBCHEM",
     "type": "PATTERN",
     "value": "^\\d+$",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "HM",
     "type": "PATTERN",
     "value": ".*",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Species",
     "type": "PATTERN",
     "value": ".*",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "TimePoint",
     "type": "PATTERN",
     "value": ".*",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Concentration",
     "type": "PATTERN",
     "value": ".*",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Anatomy",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "CellLine",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "CellStructure",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Cell",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Confidence",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Disease",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Gender",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "MeSHAnatomy",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "MeSHDisease",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Subgraph",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "TextLocation",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno",
     "value_list": []
    }
   }
  ]
 },
 {
  "statements_and_sets": [
   {
    "sets": [
     {
      "citation": {
       "type": "PubMed",
       "title": "Curr Opin Hematol. 2018 Nov;25(6):452-458. doi: 10.1097/MOH.0000000000000458.",
       "ref": "30281034",
       "pub_date": "",
       "author_list": "",
       "comment": ""
      }
     },
     {
      "set": {
       "TextLocation": [
        "Review"
       ]
      }
     },
     {
      "evidence": "There is a clear need for, and medical benefit from, blood transfusions; nonetheless, administration of red blood cells(RBCs) does result in exposure to toxicants specific to hemoglobin(Hb) and its degradation components, hemin and iron."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Blood Transfusion"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "HBB"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Blood Transfusion"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "heme"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Blood Transfusion"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "iron(2+)"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "The causes for RBC-based toxicant exposures are multifactorial; however, following acute transfusion, the most common occurs during the processes of extravascular hemolysis, which includes macrophage erythrophagocytosis followed by macrophage death [1&&], release of iron, transferrin(Tf) saturation and, finally, accumulation of labile plasma iron(LPI) [2]."
     },
     {
      "set": {
       "Cell": [
        "erythrocyte"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "HM",
         "name": "Blood Transfusion,Acute"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Phagocytosis"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Phagocytosis"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "GO",
         "name": "macrophage apoptotic process"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Phagocytosis"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "iron(2+)"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Phagocytosis"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "HP",
         "name": "Elevated transferrin saturation"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Phagocytosis"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "HM",
         "name": "Labile iron"
        },
        [
         [
          {
           "function": {
            "type": "modifier",
            "name": "location"
           }
          },
          [
           {
            "namespace": "MESH",
            "name": "Plasma"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Conversely, chronic transfusions associated with b-thalassemia major and sickle cell disease lead to hemochromatosis with end organ injury."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "HM",
         "name": "Blood Transfusion,Chronic"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Hemochromatosis"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "For example, Hb and subsequently, hemin accumulate during storage of human blood as RBC membrane integrity decreases [4]."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "HM",
         "name": "stored erythrocytes"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Erythrocyte Deformability"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Tf is an abundant plasma glycoprotein that normally circulates at a high concentration(24mg/ml) to prevent accumulation of LPI."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "TF"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "HM",
         "name": "Labile iron"
        },
        [
         [
          {
           "function": {
            "type": "modifier",
            "name": "location"
           }
          },
          [
           {
            "namespace": "MESH",
            "name": "Plasma"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "The pool of di-ferric Tf binds to erythroid cell transferrin receptor 1 (TfR1) and contributes to erythropoiesis [16]."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "MESH",
            "name": "diferric transferrin"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "HGNC",
            "name": "TFRC"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Erythropoiesis"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Acute large volume blood transfusion or administration of blood units at later stages of storage causes elevation of bilirubin, Tf saturation and LPI in animals [18&&] and humans [19&&]."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "HM",
         "name": "Blood Transfusion,Acute"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "bilirubin"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "HM",
         "name": "Blood Transfusion,Acute"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "HP",
         "name": "Elevated transferrin saturation"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "HM",
         "name": "Blood Transfusion,Acute"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "HM",
         "name": "Labile iron"
        },
        [
         [
          {
           "function": {
            "type": "modifier",
            "name": "location"
           }
          },
          [
           {
            "namespace": "MESH",
            "name": "Plasma"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Accumulation of iron in tissue parenchyma with subsequent hemochromatosis is a well-known problem in chronic transfusion-dependent diseases such as b-thalassemia major, and in sickle cell disease patients when stroke prevention is indicated."
     },
     {
      "set": {
       "MeSHDisease": [
        "Anemia, Sickle Cell",
        "beta-Thalassemia"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "HM",
         "name": "Blood Transfusion,Chronic"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Hemochromatosis"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "For example, cardiac iron accumu -lation is more common in transfused thalassemia patients, whereas liver iron accumulation is most common in transfused sickle cell disease patients."
     },
     {
      "set": {
       "MeSHDisease": [
        "beta-Thalassemia"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "HM",
         "name": "Blood Transfusion,Chronic"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Iron"
        },
        [
         [
          {
           "function": {
            "type": "modifier",
            "name": "location"
           }
          },
          [
           {
            "namespace": "MESH",
            "name": "Heart"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "set": {
       "MeSHDisease": [
        "Anemia, Sickle Cell"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "HM",
         "name": "Blood Transfusion,Chronic"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Iron"
        },
        [
         [
          {
           "function": {
            "type": "modifier",
            "name": "location"
           }
          },
          [
           {
            "namespace": "MESH",
            "name": "Liver"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Because of large exposures to iron that occur in both disorders following transfusion, patients are inevitably prescribed small molecule iron chelation and the concomitant monitoring that is required."
     },
     {
      "set": {
       "MeSHDisease": [
        "Anemia, Sickle Cell",
        "beta-Thalassemia"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Iron Chelating Agents"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "iron(2+)"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Sequestration of LPI and prevention of pro-oxidative effects by the administration of apo-Tf may have clinical relevance following acute and chronic transfusion iron overload."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "TF"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "HM",
         "name": "Labile iron"
        },
        [
         [
          {
           "function": {
            "type": "modifier",
            "name": "location"
           }
          },
          [
           {
            "namespace": "MESH",
            "name": "Plasma"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "These studies do begin to suggest that apo-Tf administration could attenuate acute iron overload and hemochromatosis progression following chronic RBC transfusions."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "TF"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "iron(2+)"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "TF"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Hemochromatosis"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Of the biological components known to bind hemin, Hpx is by far the most efficient with a dissociation constant(Kd) lower than 1 x 1013 M; as a result, after binding, the transfer of hemin from Hpx to other proteins or lipids is not possible [24]."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "HPX"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "heme"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Once bound to hemin, the Hpx-hemin complex prevents oxidative reactions and facilitates clearance of the complex through macrophage CD91, also referred to as lowdensity lipoprotein receptor-related protein 1."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "hemin"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "HGNC",
            "name": "HPX"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "HM",
         "name": "oxidative reactions"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "In mice, this response was attenuated after administration of the TLR-4 inhibitor, TAK-242, suggesting hemin potentiates pulmonary macrophage activation and inflammation through hemin-induced TLR-4 receptor binding [27]."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "heme"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "TLR4"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "heme"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Macrophage Activation"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "heme"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Inflammation"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Hp is a plasma glyco-protein that normally circulates in within a concentration range of 0.32mg/ml and is the putative scavenger of cell-free Hb with a high affinity(KD1012M) for Hb dimers(Fig. 1 A,B and Fig. 2 C [31])."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "HP"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "HBB"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "In diseases of intravascular hemolysis, Hp is often not detectable and lower Hp levels are associated with transfusion."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Blood Transfusion"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "HP"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "TextLocation"
      ]
     }
    ]
   }
  ]
 }
]